consequently , these criteria could not determine whether the first appearance of peak-dose dyskinesia depends on the duration of parkinson 's disease -- a factor that is related to the severity of the disease -- or on the duration of levodopa therapy .
C0030567
parkinson 's disease
C0023570
levodopa